Brief: Akari Therapeutics Moving Forward Into Design And Planning For Part B Of Phase 3 Clinical Trial Of Nomacopan
13/02/2023 13:28
Feb 13 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS PLC - ANNOUNCES IT IS MOVING FORWARD
INTO
DESIGN AND PLANNING FOR PIVOTAL PART B OF PHASE 3 CLINICAL TRIAL
OF NOMACOPAN
* AKARI THERAPEUTICS PLC - ANNOUNCES INITIATION OF A NEW
PIPELINE
PROGRAM FOR DEVELOPMENT OF NOMACOPAN AS A POTENTIAL TREATMENT
FOR ADULTS WITH HSCT-TMA
Source text for Eikon: ID:nGNE7xb3xl
Further company coverage: AKTX.O
((Reuters.Briefs@thomsonreuters.com;))